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Abstracts / Osteoarthritis and Cartilage 22 (2014) S7–S56S10the secondary outcomes ICOAP intermittent and constant pain (stat-
istically signiﬁcant and clinically relevant differences between the
groups at 3 months but not at 12 months follow-up), but not for the
other outcomes (no differences between the groups at 3 months and at
12 months follow-up). No adverse events were reported during the
study.
Conclusions: At 3 months follow-up there was a statistical signiﬁcant
difference between the treatment groups in favor of the group allocated
to exercise therapy on the primary outcomes HOOS pain and HOOS
function and also in the secondary outcome ICOAP. At 12 months fol-
low-up there were no statistical differences between the treatment
groups.
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NEW INSIGHTS INTO MOUSE LIMB SYNOVIAL JOINT
MORPHOGENESIS BY GDF5-CRE AND GDF5-CREERT2 CELL LINEAGE
TRACING
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Purpose: Throughout our lifespan, maintenance of synovial joint
integrity is essential for quality of life. While much is known about the
susceptibility of synovial joints to common pathologies such as age-
dependent and post-traumatic osteoarthritis, basic information about
their developmental biology is surprisingly limited. Previously, research
from our group demonstrated that Gdf5-expressing mesenchymal
interzone cells forming at presumptive limb joint sites give rise to
multiple joint tissues during embryonic development including artic-
ular cartilage, ligaments and synovial lining. What had remained
unknown, however, is whether spatiotemporal differences in genesis of
Gdf-5 expressing cells results in selective participation in development
of speciﬁc joint tissues, and what roles Gdf-5 expressing cells may have
in postnatal joint phenotype and function. To address these and related
questions, we carried out detailed Gdf-5 cell lineage tracing during late
embryonic and postnatal joint development using our existing Gdf5-
Cre mouse line as well as a novel Gdf5-CreERT2 line.
Methods: Female Gdf5-Cre transgenic mice were mated with male
ROSA-mTomato/mGFP (mTmG) reporter mice which express con-
stitutive red ﬂuorescence prior to, and conditional green ﬂuorescence
following, Cre-mediated recombination. Offspring were harvested at
embryonic day 18.5 (E18.5) and postnatal day 0, 14 or 28 (P0, P14 or
P28). Female mice from our new Gdf5-CreERT2 transgenic strain were
mated with male ROSA-tdTomato reporter mice which express red
ﬂuorescent protein in cells following Cre-mediated recombination.
Gdf5-CreERT2 females were injected with tamoxifen at E14.5 and E15.5,
and resulting embryos were harvested at E18.5.
Results: Cre-dependent lacZ reporter strains (ROSAR26R) are widely
used for cell lineage and fate map tracing. However, endogenous b-
galactosidase expression in postnatal skeletal tissues leads to back-
ground staining and difﬁculties in interpreting Cre expression patterns.
Indeed, b-galactosidase staining of sections from P14 Gdf-5Cre;R26R
mouse knees was present in bone areas (Figure 1A, arrows) in addition
to predicted expression patterns in articular cartilage (AC, arrowhead),
synovial lining (SL, arrowhead) and capsule tissue (CT, arrowhead). In
contrast, expression of mGFP in complementary Gdf-5Cre;ROSA-mTmG
mice was limited to articular cartilage, synovial lining and capsule tis-
sue (Figure 1B, arrowheads). When tamoxifenwas injected at E14.5 and
E15.5 in our novel Gdf5-CreERT2;ROSAtdTomato mice, we found that
selective labeling was present in superﬁcial articular cells and synovial
lining by E18.5 (Figure 2,A). In comparison, continuous joint progenitor
labeling in standard Gdf-5Cre;ROSA-mTmG mice generated broader
labeling of articular cell layers and synovial cells (Figure 2, B). To
monitor fate and function of labeled cells, Gdf-5Cre;ROSA-mTmG mice
were sacriﬁced at successive postnatal ages. In neonatal mice, mGFP-
expressing cells were present throughout the epiphyseal articular car-
tilage of femur, extending several cell layers below the articular surface
(Figure 2, C). Interestingly, the mGFP expression patterns became more
restricted by P14, with several mGFP-negative cells present in the two
most superﬁcial cell layers (Figure 2D). Patterns of decreasing expres-
sion at the articular surface continued through P28 (Figure 2E).
Conclusions: Our data demonstrate the exciting potentials of the new
novel Gdf5-CreERT2 mouse line for studying spatiotemporal Gdf-5
activation in developing joints and indicate that CreER activation atE14.5 and E15.5 elicits reporter expression conﬁned to the most
superﬁcial layer of developing E18.5 articular cartilage. The constitutive
Gdf5-Cre line instead elicits reporter expression in several articular
layers by the same age. Though preliminary, the data from the novel
Gdf5CreER line suggests that sub-populations of progenitor cells exist
within a broader region of cells labeled by Gdf5Cre, hinting at their
diverse joint formation capacity. Our data from postnatal Gdf-5Crex-
ROSAmTmG mice indicate that not all articular chondrocytes are
reporter positive by P14 and P28. One possibility is that reporter
expression was partially lost over time. A far more interesting possi-
bility is that there may be an additional source of postnatal articular
progenitors, such as the groove of Ranvier.8
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Figure 1. In vitro chondrogenic differentiation assay (n¼3) (a and b)
Representative stereo microscope images of Overall morphology of
chondrogenic pellets differentiated from control and FOCD BM-MSCs.
Pellets were harvested at day 14. White scale bars¼1 mm. (c and d)
Representative images of toluidine blue staining on the sections of these
corresponding pellets are shown. Scale bars¼200um. (e and f) The images
of immunostaining pellets’ sections with aggrecan antibody are shown.
Figure 2. Confocal microscopy images showing double Staining of
aggrecan (red) and GRP78/Bip (green). Cell nuclei stained with DAPI
(blue). The merged images indicated the relative location of aggrecan and
Bip. Overlapping areas appeared yellow. Scale bar¼20um. Samples were
harvested at day 42.
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Purpose: Familial osteochondritis dissecans (FOCD) is an inherited
cartilage defect characterized by multiple joint involvement, short
stature and early osteoarthritis. We have studied a family from
Northern Sweden (NS) with FOCD over ﬁve generations with all
affected family members having a heterozygous missense mutation
on exon 17 of the aggrecan gene. Privious study showed that this
mutation results in a Val-Met amino acid replacement (V2303) in the
G3 aggrecan C-type lectin domain (CLD). The aims of the study were
to investigate the pathogenesis of FOCD-NS by examining chondro-
genesis of patient-derived bone marrow mesenchymal stem cells
(BM-MSCs) and induced pluripotent stem cells (iPSCs). This approach
has given us a fascinating insight into the cellular pathology of the
condition.
Methods: BM-MSCs were obtained after institutional ethical appro-
val and informed consent from a 33 year-old male healthy donor and
a 49 year-old male patient. The cells were characterized by ﬂow
cytometry and tri-lineage differentiation. Chondrogenic pellets,
derived from control and patient BM-MSCs, were harvested to study
the effects of the mutation on early and late chondrogenesis. Tolui-
dine blue staining was carried out to detect glycosaminoglycan (GAG)
and immunohistochemistry (IHC) used to detect proteins of interest.
The ultrastructure of cell organelles was examined by transmission
electron microscopy (TEM). Mass spectrometry was employed to
analyze the composition of extracellular matrix (ECM). Because of
the difﬁculties in obtaining marrow samples from patients and the
low yield of MSCs from this source, we generated patient-speciﬁc
iPSCs from skin ﬁbroblasts of two FOCD-NS patients, a 25 year-old
son and 49 year-old mother. To assess the pluripotency of iPSCs
generated, RT-PCR for pluripotency genes, teratoma assay and kar-
yotype analysis were performed. One non-patient iPSC line was used
as a positive control in all experiments. To validate the disease
phenotype, cartilage formed in patient iPSC-derived teratoma was
also analyzed.
Results: All BM-MSCs expressed typical surface markers and were
capable of tri-lineage differentiation. Chondrogenic differentiation in
vitro revealed an irregular discoid morphology of patient pellets. An
intracellular distribution of aggrecan in FOCD-NS pellets was observed
at early stages of differentiation. Multiple immuno-staining of aggre-
can and Bip, a marker of rough endoplasmic reticulum (rER), further
conﬁrmed that the mutated aggrecan was retained in the rER during
chondrogenic processing. Membrane expansion of the rER was also
detected in chondrocytes derived from patient BM-MSCs at day 56,
indicating a prolonged folding defect within the organelle. Although
collagen type II was produced by patient chondrocytes, TEM showed
that they failure to assemble a normal ECM. GAGs distribution
appeared normal in patient pellets during early chondrogenesis, which
suggested that the non-mutated aggrecan allele was expressed. We
cultured these pellets for up to 100 days to assess the impact during
tissue maturation. The results of mass spectrometry on protein isolated
from these pellets showed while the aggrecan G1 domain was pre-
sented in equal amounts in both groups, the G2 and G3 domains were
reduced by approximately 50% in the patient pellets. Comparing the
amount of other ECM proteins indicated that the composition of
matrix was markedly different between control and patient. Four
patient-derived iPS cell lines were morphologically, genetically and
functionally similar to human embryonic stem cells. Detection of
aggrecan in the cartilage differentiated from these showed the same
disease phenotype found in chondrogenic pellets derived from the
BM-MSCs.
Conclusion: Our ﬁndings concluded that the V2303 mutation results in
folding defect aggrecan G3 domain, which prevents processing of the
protein core through rER. The accumulation of intracellular aggrecan
results in an enlarged rER area and affects the function of FOCD-NS
chondrocytes in assembling normal ECM. Although the non-mutated
aggrecan was produced to a certain extent, it could not reverse the
pathology of the disease during chondrogenesis. ECM with disrupted
composition and reduced aggrecan levels could affect the mechanical
properties of FOCD-NS cartilage. This study revels how insight into
disease mechanism can be obtained by studying the regulation of dif-
ferentiation of progenitor cells. It also provides, for the ﬁrst time, a
model of inherited osteoarthritic disease based on patient-derived iPS
cells, and sheds further light on the critical role of the CLD in aggrecan
folding and in normal matrix assembly.9
IS LONG-TERM PHYSICAL ACTIVITY SAFE FOR OLDER ADULTS WITH
KNEE PAIN?: A SYSTEMATIC REVIEW
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Purpose: Knee pain attributable to osteoarthritis (OA) is common in
older adults. Although exercise and physical activity are consistently
recommended for older adults with knee pain in clinical guidelines,
physical activity levels in this population remain low. This may, in part,
be due to concerns over its long-term safety. Common and persisting
narratives regarding joint “wear and tear” may lead to attributions that
physical activity causes further joint damage, whilst pain during activity
may be perceived as an indicator of harm. The aim of this study was to
synthesise existing literature to determine whether long-term physical
activity is safe for older adults with knee pain.
Methods: A comprehensive systematic review was conducted using
multiple electronic databases including MEDLINE, EMBASE, CINAHL,
CENTRAL, AMED, SPORTDiscus, CISDOC, NIOSHTIC-2 and HSELINE from
inception until 16th May 2013. Two reviewers independently screened
all titles, abstracts and full texts for study inclusion and exclusion
